Opioid Use Disorder: Treatment With Injectable & Implantable Buprenorphine
July 18, 2025
In August 2020, the U.S. Government Accountability Office (ACO) published a report focused on injectable and implantable controlled substances that can be used to treat opioid use disorder (OUD), and specifically, describes the process for treating OUD with injectable and implantable buprenorphine and what is known about their use.
Want to Read more?
To view this content, please sign up or log in to your account.
Create an account in seconds or log in if you’re already a member.
Sign Up
